SANDERS MORRIS HARRIS LLC - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SANDERS MORRIS HARRIS LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$8,989,000
+179680.0%
537,960
+57.6%
4.37%
+87380.0%
Q1 2020$5,000
-100.0%
341,250
-29.9%
0.01%
-99.8%
Q3 2019$10,196,000
+87.6%
486,906
+86.5%
2.47%
+74.9%
Q2 2019$5,436,000–261,106–1.41%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q2 2020.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders